CSPC Pharmaceutical Group Limited
CHJTF
$1.28
$0.0756.25%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -22.92% | -16.33% | -16.80% | -11.98% | 6.30% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -22.92% | -16.33% | -16.80% | -11.98% | 6.30% |
| Cost of Revenue | -8.35% | -8.33% | -6.04% | -10.18% | -6.48% |
| Gross Profit | -28.50% | -19.59% | -21.12% | -12.71% | 12.17% |
| SG&A Expenses | -43.37% | -8.09% | -13.47% | -23.74% | 14.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.87% | -3.75% | -8.02% | -13.36% | 5.23% |
| Operating Income | -26.52% | -57.04% | -47.50% | -6.98% | 10.11% |
| Income Before Tax | -13.87% | -53.01% | -50.45% | -11.26% | 10.14% |
| Income Tax Expenses | -30.58% | -15.24% | -42.76% | -0.24% | 30.90% |
| Earnings from Continuing Operations | -9.48% | -62.32% | -52.10% | -13.43% | 5.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.61% | 128.64% | 110.78% | 73.23% | 59.67% |
| Net Income | -9.55% | -59.96% | -49.82% | -11.45% | 7.57% |
| EBIT | -26.52% | -57.04% | -47.50% | -6.98% | 10.11% |
| EBITDA | -22.14% | -48.44% | -41.30% | -4.03% | 9.32% |
| EPS Basic | -6.84% | -59.01% | -49.44% | -11.35% | 8.57% |
| Normalized Basic EPS | -10.74% | -46.38% | -48.03% | -7.09% | 12.88% |
| EPS Diluted | -6.84% | -59.01% | -49.44% | -11.35% | 8.57% |
| Normalized Diluted EPS | -10.74% | -46.38% | -48.03% | -7.09% | 12.88% |
| Average Basic Shares Outstanding | -3.39% | -2.43% | -1.18% | -0.35% | -0.56% |
| Average Diluted Shares Outstanding | -3.39% | -2.43% | -1.25% | -0.36% | -0.56% |
| Dividend Per Share | -- | -21.47% | -- | 12.57% | -- |
| Payout Ratio | -- | -- | -- | -- | -- |